Dimethyldithiocarbamate inhibits in vitro activation of primary human CD4+ T lymphocytes

Toxicology

Volumn 128, Issue 2, 1998, Pages 83-90

  Pyatt, David W ^a   Gruntmeir, Jennifer ^a   Stillman, Wayne S ^a   Irons, Richard D ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Dimethyldithiocarbamate; Human; NF B; T lymphocytes

Indexed keywords

CD4 ANTIGEN; DIMETHYLDITHIOCARBAMIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOTOXICITY; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

CD4-POSITIVE T-LYMPHOCYTES; DIMETHYLDITHIOCARBAMATE; FLOW CYTOMETRY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; NF-KAPPA B; RECEPTORS, INTERLEUKIN-2; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 0032479538     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(98)00047-X     Document Type: Article

References (23)

1. Brennan, P., O'Neill, L., 1996. 2-Mercaptoethanol restores the ability of nuclear factor κB (NFκB) to bind DNA in nuclear extracts from interleukin 1-treated cells incubated with pyrollidine dithiocarbamate (PDTC). Biochem. J. 320, 975-981.
2. Bagasra, O., Wright, S.D., Seshamma, T., Oakes, J.W., Pomerantz, R.J., 1992. CD14 is involved in control of human immunodeficiency virus type 1 expression in latently infected cells by lipopolysaccharide. Proc. Natl. Acad. Sci. USA 89, 6285-6289.
3. Cogswell, P.C., Scheinman, R.I., 1993. Promoter of the human NF-κB p50/p105 gene: regulation by NF-κB subunits and by c-rel. J. Immunol. 150, 2794-2804.
4. Dignam, J.D., Lebovitz, R.M., Roeder, R.G., 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475-1489.
5. Dinter, H., Chiu, R., Imagawa, M., Karin, M., Jones, K.A., 1987. In vitro activation of the HIV-1 enhancer in extracts from cells treated with a phorbol ester tumor promoter. EMBO J. 6, 4067-4071.
6. Hoyos, B., Ballard, D., Bohnlein, E., Siekevitz, M., Greene, W., 1989. Kappa B-specific DNA binding proteins: role in the regulation of human interleukin-2 gene expression. Science 244, 457-460.
7. Ivanov, V., Merkenschlager, M., Ceredig, R., 1993. Antioxidant treatment of thymic organ cultures decreases NF-κB and TCF-1(α) transcription factor activities and inhibits αβ T cell development. J. Immunol. 151, 4694-4704.
8. Kaldjian, E., McCarthy, S.A., Sharrow, S.O., Littman, D.R., Klausner, R.D., Singer, A., 1988. Nonequivalent effects of PKC activation by PMA on murine CD4 and CDS cell-surface expression. FASEB J. 2, 2801-2806.
9. Lombardi, P., Fournier, M., Bernier, J., Mansour, S., Neveu, P., Krzystyniak, K., 1991. Evaluation of the immunomodulatory potential of diethyl dithiocarbamate derivatives. Int. J. Immunopharmacol. 13, 1073-1084.
10. Nobel, C.S.I., Kimland, M., Lind, B., Orrenius, S., Slater, A.F.G., 1995. Dithiocarbamates induce apoptosis in thymocytes by raising the intracellular level of redox-active copper. J. Biol. Chem. 270, 26202-26208.
11. Orrenius, S., Nobel, C.S.I., Van den Dobbelsteen, D.J., Burkitt, M.J., Slater, A.F.G., 1996. Dithiocarbamates and the redox regulation of cell death. Biochem. Soc. Trans. 24, 1032-1038.
12. Osborn, L., Kunkel, S., Nabel, G.J., 1989. Tumor necrosis factor α and interleukin-1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κB. Proc. Natl. Acad. Sci. USA 86, 2336-2340.
13. Ostrove, J.M., Leonard, J., Weck, K.E., Rabson, A.B., Gendelman, H.E., 1987. Activation of the human immunodeficiency virus by herpes simplex virus type 1. J. Virol. 61, 3726-3732.
14. Padgett, E.L., Barnes, D.B., Pruett, S.B., 1992. Disparate effects of representative dithiocarbamates on selected immunological parameters in vivo and cell survival in vitro in female B6C3F1 mice. J. Toxicol. Environ. Health 37, 559-571.
15. Pruett, S.B., Barnes, D.B., Han, Y.C., Munson, A.E., 1992. Immunotoxicological characteristics of sodium methyldithiocarbamate. Fundam. Appl. Toxicol. 18, 40-47.
16. + T lymphocytes. Biochem. Biophys. Res. Commun. 227, 380-385.
17. Schmitz, M.L., 1995. Function and activation of the transcription factor NF-κB in the response to toxins and pathogens. Toxicol. Lett. 82/83, 407-411.
18. Schreck, R., Meier, B., Mannel, D.N., Droge, W., Baeuerle, P.A., 1992. Dithiocarbamates as potent inhibitors of nuclear factor-κB activation in intact cells. J. Exp. Med. 175, 1181-1194.
19. Schulze-Osthoff, K., Beyaert, R., Vandevoorde, V., Haegeman, G., Fiers, W., 1993. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J. 12 (8), 3095-3104.
20. Thanos, D., Maniatis, T., 1995. NF-κB: a lesson in family values. Cell 80, 529-532.
21. Thelen, U., Wirthmueller, U., 1994. Phospholipases and protein kinases during phagocyte activation. Curr. Opin. Immunol. 6, 106-112.
22. Weiss, A., Imboden, J.B., 1987. Cell surface molecules and early events involved in human T lymphocyte activation. Adv. Immunol. 41, 1-31.
23. Ziegler-Heitbrock, H.W.L., Sternsdorf, T., Liese, J., Belohradsky, B., Weber, C., Wedel, A., Schreck, R., Bauerle, P., Strobel, M., 1993. Pyrrolidine dithiocarbamate inhibits NF-κB mobilization and TNF production in human monocytes. J. Immunol. 151, 6986-6993.